We have previously isolated, and characterized in vitro, two subsets of CD4 hi T cell receptor (TCR) hi single positive (SP) thymocytes: CDS-and CD81~ In this report, we tlave analyzed phenotypic, functional, and developmental characteristics of these "late" CD4 hi SP thymocyte subsets. The TCK h~ phenotype and the elimination of T cells expressing TCK Vo segments reactive with endogenous mouse mammary tumor virus (MMTV) products suggested that both subsets had undergone positive and negative selection. CD8-4 hi thymocytes were functional, as judged by their ability to: (a) induce lethal graft versus host disease (GVHD); (b) survive and expand in peripheral lymphoid organs; and (c) proliferate, rather than undergo apoptosis, in response to in vitro TCK cross-linking. By contrast, CD81~ ha cells could not induce GVHD, were unable to expand (and perhaps even survive) in peripheral organs and underwent apoptosis upon TCK cross-linking. However, when reintroduced into the thymus, these cells matured into functional, long-lived CD8-4 hi lymphocytes. These results document an obligatory requirement for the thymic microenvironment in the final maturation of the majority of CD4 hi SP postselection thymocytes, and demonstrate the existence of a previously unrecognized control point in T cell development.
T
CR-a/fl T cells develop in the thymus from immature precursors via an ordered sequence of phenotypic and functional changes (reviewed in [1] [2] [3] . The majority of the early T cell precursors express neither CD8 nor CD4 coreceptor molecules and are therefore described as CDS-4-double-negatives (DN)k After successful TCK-fl rearrangement (4--6) , and other less well-defined events, these cells begin to express both CD4 and CD8 on the cell surface, initially at very low (7, 8) and then at high membrane density, to become CD8hi4 hi double-positive (DP) thymocytes. In the course of further maturation, positively selected DP cells downregulate one of the accessory molecules and upregulate the TCK to become TCK hi cells of the CD8-4 + or CD8+4 -single-positive (SP) phenotype.
SP thymocytes have generally been regarded as functional equivalents of mature, peripheral SP T cells, despite phenotypic differences between thymic and peripheral subsets in the expression of several molecules, including CD24 (heat stable antigen [HSA] , low on SP thymocytes and negative on peripheral SP, except for recent thymic emigrants), and Qa-2 (low on Sp thymocytes and high on peripheral SP) (9) (10) (11) (12) . However, we have demonstrated that "o70% of the CD4 § TCPx hi SP thymocytes express very low levels of CD8 (undetectable by flow cytometry [FCM] ), intermediate levels of HSA, and are hyporesponsive to in vitro allogeneic stimulation in the absence of exogenous IL-2 (13) . By contrast, the remaining 30% of CD4+TCK hi SP cells do not express CDS, are HSA 1~ and are self-sufficient in an in vitro allogeneic response. Ramsdell et al. (14) obtained similar results, using Qa-2, rather than CD8, as a criterion for subdividing the CD4 + SP thymocytes. To better understand the final steps in intrathymic maturation, we further examined the in vivo and in vitro behavior of these subsets. Throughout the text, we shall use the term CD4 hi SP for both cell subsets, since they are indeed SP by FCM; when the CD8 l~ phenotype is mentioned, it refers to levels of CD8 undetectable by FCM, and detectable by panning; see Materials and Methods, Fig. 1 , and reference 13). We show that purified CD8]~ hi thymocytes neither function nor expand in the periphery. However, these cells can develop into mature, functional CD4 hi cells if reintroduced into the thymus. Thus, the majority of CD4hiTCR hi SP thymocytes still depend on the thymus for terminal maturation.
Materials and Methods
Mice. BALB/c, C57BL/6 (B6), CB6F1, and B6D2F1 female mice were purchased from the National Cancer Institute animal facility (Frederick, MD). B6.PL and BALB/c nu/nu breeding pairs were originally obtained from The Jackson Laboratory (Bar Harbor, ME) and were maintained at the Memorial Sloan-Kettering Cancer Center. Animals were used at 5-10 wk of age, and were age-and sex-matched for each experiment.
Reagents. mAbs against CD8 (3.168, reference 15), CD4 (ILL 172.4) and CD25 (PC-61) (16) , CD24 (J11d) and Thy-l.2 (J1J) (17) , CD24 (M1/69, reference 18) TCR18 (H57-597, reference 19) , Va8 (F23.1, reference 20), Thy-l.1 (19E12, reference 21) , and CD44 (IM 7.8, reference 22) were produced in our laboratory as tissue culture supernatant or ascites fluid, and were used without modifications or following conjugation to FITC. Goat anti-rat IgG (GARIG; cat. no. R2129) and Con A (both from Sigma Chemical Co., St. Isolation of Cell Subsets. Cytotoxic elimination by mAb and complement (C'), positive and negative selection of thymocytes by panning, and FCM sorting were performed as described previously (13) . Thymocyte subsets were purified from c~CD8 + C' treated thymocytes by panning on GARIG, and both adherent (ccCD8-coated cells that survived complement treatment, since they are CD8 l~ and nonadherent (CD8-) cells further selected for CD4 hi expression by either panning or FCM sorting (97-99.5% purity, by FCM analysis). This standard procedure was varied in order to confirm the phenotype of isolated cells and exclude the masking of CD8 molecules at the surface of DP or CD8 in' cells. Thymocytes were separated into CDS-adherent and CDS-nonadherent fractions by panning, and were then sorted without cytotoxic depletion into CDSI~ h~ cells (CD4 SP gate from CD8-adherent cells) and CD8-4 hi cells (CD4 SP gate from CD8-nonadherent cells). This isolation procedure yielded cells with identical phenotype to CD81~ hi and CD8-4 hl cells obtained by a combination of cytotoxic depletion and panning. Splenic CD8-4 hi cells (>96% pure) were obtained by eliminating CD24 + (B cells and macrophages) and CD8 § cells by mAb + C' and subsequent positive selection of surviving cells by panning.
FCMAnalysis. Staining protocols, controls and marker placement were described in (13) , except that experiments were performed using a FACScan | instrument, equipped with the LYSYS II software (Becton Dickinson & Co.). 5-20 x 103 events were analyzed per sample. TCR V~ expression was determined by single-color staining using directly conjugated anti-V~ mAb. A lack of expression of certain Va's owing to MMTV-mediated deletions was used as an internal negative control. Results were normalized to the expression of TCR.
For the analysis of DNA fragmentation, 106 cells from each population were incubated overnight in 24-well plates (Costar Corp., Cambridge, MA) in 2 ml of standardly supplemented KPMI/10% FCS. The wells were precoated with 100 #g/ml of mAb 597 or with PBS. Dexamethasone (10 -9 M) was used as a positive control. The percentage of cells displaying subdiploid DNA content was determined by FCM, exactly as described previously (23) . For the cell cycle analysis, purified thymocyte subsets were fixed overnight in 70% ethanol, washed, resuspended in PBS containing 1,000 Kunitz units RNase, and stained with propidium iodide (500 ng/ml). These samples were acquired using the doublet-discrimination module of the FACScan | by dually gating on forward and side scatter and FL-2 area vs. width, to eliminate the inclusion of cell doublets. Cell cycle distribution was then analyzed using Multicycle software (Phoenix Flow Systems, San Diego, CA).
"Lethal" GVHD 1 or 2 x 106 cells of each subset isolated from BALB/c (H-2 a) donors were injected into the tail vein of lethally irradiated (9.5 Gy) F1 hosts (CB6F1 or B6D2FI, both H-2bxd), reconstituted with 107 T cell-depleted (J1J + C') bone marrow cells of donor type. The animals were then observed daily until euthanized when it was judged necessary, or for over 100 d. Clinical signs of the disease included raised fur, weight loss, and loss of motility. Euthanasia was performed when the GVHD became so severe that the animals were no longer able to move around the cage and take food or water. This stage was defined as the endpoint, and the GVHD was deemed lethal. Uninjected, but irradiated and reconstituted animals were used as controls. These mice did not exhibit any symptoms of the GVHD.
T Cell Subset "Parking" into nu/nu Recipients. 2 x 106 purified thymocytes or splenocytes from BALB/c +/+ mice were injected intravenously into BALB/c nu/nu recipients. Recipients were prescreened against the presence of T cells in peripheral blood by FCM. Spleen and mesenteric lymph node cells of injected and control animals were analyzed for CD4 and CD8 expression at indicated times. Uninjected mice were used as controls.
Intrathymic Injection of T Cell Subsets. 1-2 x 106 C57BL/6 (H-2 b, Thy-l.2 § cells of each subpopulation were injected intrathymically into lethally irradiated (9.5 Gy), syngeneic, T cell-depleted (19E12 + C') bone marrow-reconstituted B6.PL (H-2 b, Thy-l.1) recipients, exactly as described (24) . On day 7 post injection, and every third day thereafter, the mice received an intraperitoneal injection of 19E12 ascites (100 #l/animal) to deplete host-type T cells. At indicated times, spleen and mesenteric lymph node cells were analyzed for the presence of CD4 § Thy-l.2 + and CD8 § T Thy-1.2 + expression by two-color FCM.
Proliferation Assay. Spleen cells from mice intrathymically injected with thymocyte and splenocyte subsets >36 d before were analyzed for their ability to proliferate in response to 4 #g/ml of Con A. 10 s spleen cells were seeded in 96.weU flat-bottomed plates (Falcon Labware; Becton Dickinson & Co.) in 0.2 ml of completely supplemented RPMI medium in the presence or absence of Con A. 90 h later, each well was pulsed with 1 #Ci [3H]TdR (New England Nuclear, Boston, MA). 6 h later, cells were harvested and the degree of incorporation of radiolabeled thymidine determined in a beta-counter (Pharmacia LKB, Piscataway, NJ). Results are represented as the mean of triplicate wells _+ standard error.
Results

Expression of Developmental Markers and the TCR V# Repertoire of CD4 hi Thymocyte Subsets.
A thymocyte subset named CD81~ hi was previously described by two groups (25) (26) (27) . In these experiments, CD81~ hi cells were defined by electronic FCM gating as the cells bearing CD8 levels four to five times lower than those on typical DP thymocytes, but higher than those seen on SP cells, and were shown to bear the TCRintCD24hiCD441~ hi phenotype (25, 26) . Furthermore, this population contained cells bearing Vo TCRs reactive with products of endogenous mouse mammary tumor viruses (MMTVs), that are eliminated from the mature T cell pool, suggesting that negative intrathymic selection may be incomplete in this intermediate subset (25) . Based on this finding, it was concluded that CD81~ hi cells may have undergone positive but not negative selection (25) . In 1990, we described a delineation of CD4 hi SP cells into CD8-and CD81~ subsets and showed that they express high levels of CD4 and TCR, similar to those found on fully mature peripheral cells (13) . CD8 expression was undetectable by FCM on CD81~ cells, and, as discussed previously, could only be detected by panning. By phenotypic and functional criteria, both subsets looked like bona fide SP thymocytes, but differed in requirements for the in vitro proliferation (13) . We therefore hypothesized that CD81~ hi phenotype marks a late stage in the intrathymic development, immediately before complete downregulation of CD8 and migration to the periphery. Because the CD81~ hi cells described by other groups bear CD8 levels clearly detectable by FCM (25) (26) (27) , these cells were different from our CD81~ ~ thymocytes, and would better be characterized as CD8 int.
It was, however, formally possible that our CD81~ hi cells actually were CD8 ~, i.e., identical to CD81~ hi cells described by other groups, but that their CD8 was masked by cytotoxic treatment used to deplete CD8 hi (DP) cells. We considered this possibility unlikely because secondary reagents (e.g., GARIG-FITC), as well as noncompeting antibodies (e.g., anti-CD8c~ for depletion and anti-CD83 for staining), revealed no such blocking (not shown). Furthermore, direct sorting of CD4 hi SP cells from thymocyte suspensions that have not been subjected to cytotoxic treatment yielded cells bearing an identical phenotype to cells obtained by a combination of c~CD8 + C' and panning (not shown). However, to independently test this possibility, we performed an extended phenotypic analysis of gated CD8~t4 hi cells (using the gates described by Guidos et al. [25] , and Bendelac et al. [26, 27] ) and CD8-4 hi and CD81~ hi thymocytes (isolated as described in Materials and Methods), using total thymocytes as the reference point. In a typical experiment using BALB/c thymocytes ( Fig. 1 A) , all populations were generated from the same starting population (total thymocytes), either by selective gating (CD8 i"t) or by a combination of positive and negative selection by mAb + C' and panning (CD81~ and CDS-cells). The cells were triple-stained to reveal the ex-
CD69 CD~ (left) or CD44 (right). In this experiment, CD81~ hi calls were 82.3% CD69", 79.9% CD44", and CD8-4 hi cells were 54.7% CD69 +, 86.1% CD44 +, based on the marker placement to demarcate fluorescence higher than that of isotype-stained control. Both cell preparations were <1% CD8 + and >98% CD4 hi.
pression CD4, CD8, and the third marker, as shown in Fig.  1 A. Total thymocytes contained the major TCR-/TCR 1~ population, a minor TCR hi population, and a TCR int population between those two. While CD8int4 hi cells were TCR int (mean fluorescence intensity [MFI] = 261), both CDSl~ hi and CD8-4 hi cells were TCR hi, with a slight difference between the two in TCR intensity (364 vs. 380 MFI). CD24 showed the opposite trend; levels were very high and virtually identical on total thymocytes and CD8int4 hi cells, were reduced to a third on CD81~ hi cells, and to less than a fourth in CD8-4 hi cells, in accordance with previous reports (13, 14) . The expression of an early "activation" marker CD69 (25-28) correlated well with the expected maturational status of thymocyte subsets; its intensity was the highest on the most immature CD8i~t4 hi cells, and progressively decreased in CD81~ hi and CD8-4 hi cells, to reach "~45-55% of CD8-4 hi cells that are intermediate to low for CD69 expression ( Fig. 1, A and B), consistent with previous results (25) (26) (27) . The intensity of expression of Mel-14 (L-selectin) was relatively uniform on all subsets analyzed, although CD81~ hi thymocytes showed the most homogenous MEL-14 + staining pattern. CD4 expression was high in all populations, while that of CD8 was intermediate (as gated) on CD8int4 hi cells (roughly fourfold lower than that on total thymus) and negative on CD81~ hi and CD8-4 hi cells. Expression of CD44 increased with maturation, so that CD8 int cells were largely low, while CD81~ and CDS-cells were almost identically high ( Fig. 1 B and not shown). That trend was more obvious in B6 mice ( Fig. 1 B) , where the CD44 expression is generally lower, than in BALB/c (not shown). Qa-2, a late differentiation antigen, was expressed at low levels on the most mature, CD8-4 hi cells and was negative on other populations analyzed (not shown), in accordance with previous results of Ramsdell et al. (14) . The expression of endogenous MMTV-reactive VO TCRs on thymocyte subsets is shown in Fig. 2 . This analysis revealed that the elimination of self-reactive Vt3's (V~3 and V~11 in this experiment) had occurred in both CD81~ hi and CD8-4 hi thymocytes. This feature further distinguishes our CD81~ hi cells from the CD81~ hi (more accurately CD8int4 hi) cells described by Guidos et al. (25) and Bendelac et al. (26, 27) , in which the elimination was incomplete (Fig. 2) . Therefore, both the CD81~ hi and CD8-4 hi thymocyte subsets have the TCR phenotype of postselection thymocytes, based on the high TCR expression and the elimination of cells bearing self-reactive Vas.
Together, these results show that CD8b4 hi ceUs are a distinct thymocyte subset, phenotypically more mature than the previously identified CDSint4 hi ceils, but less mature than CD8-4 hi thymocytes. These three stages probably represent a continuum of phenotypic changes that occur as a consequence of intrathymic (selectional) contacts at an earlier stage (perhaps DP) in development. In the remaining part of this work, we sought to determine whether additional intrathymic contacts were required for the progression through the final stages of intrathymic development.
In Vivo Responsiveness of CD4 + Thymocyte Subsets. In our previous experiments, both CD81~ hi and CD8-4 hi thymo-
[AlJJl~'~; Vb11 cytes were shown to be restricted by MHC class II and not class I molecules. However, while CD8-4 ~ thymocytes were fully capable of proliferating to aUogeneic stimulation in vitro, CD81~ hi cells required exogenous IL-2 (13). To establish whether the in vitro responsiveness of CD8~4 hi and CD8-4 hi thymocytes was indeed representative of their function in vivo, thymocyte subsets were injected intravenously into semiallogeneic irradiated hosts. In such a test, mature splenic CD8-4 hi cells (positive control) readily induced lethal GVHD (Table 1) . In all experiments performed to date, Purified cell subsets (2 x 106 cells/recipient) were injected into lethally irradiated (9.5 Gy) and reconstituted F1 recipients as described in Materials and Methods. Animals were maintained on acidified water and observed daily for signs of GVHD. Lethal GVHD was determined as described in Materials and Methods. Results are expressed as the number of mice surviving/total number of tested mice, with length of survival shown in parentheses.
CD8-4 ~ thymocytes were at least as eflqcient as their splenic counterpart in inducing acute GVHD. By contrast, the CDSl~ hi subset failed to mount a GVHD response, and the animals that received these cells enjoyed a long-term survival equivalent to the control group ( 
CD81~ hi Thymocytes Fail to Expand (and May Fail to Survive) in Peripheral Lymphoid
Organs. Several hypotheses, including the functional incompetence, the inability to survive in the periphery and the inability to properly home to lymphoid organs, could explain the failure of CD81~ hi cells to induce GVHD. To address these possibilities, we asked whether CD81~ hi cells could popuhte the peripheral lymphoid organs of athymic syngeneic hosts after intravenous transfer. Transfer of either splenic or thymic CD8-4 hi cells resulted in a selective and progressive increase of CD4 + ceU numbers in lymphoid organs of syngeneic nude recipients (Table 2 ). This result indicated that donor cells not only populated host lymphoid organs, but also proliferated there. For example, 2 x 106 ceils injected on day 0 yielded by day 42 an average increase in CD4 + cell number by 6.3 x 106 ceils (thymic CD8-4 hi) and 5.7 x 106 cells (splenic CD8-4 hi cells) in donor spleens alone (experiment 2, Table 2 ). Assuming that the injected cells distributed equally throughout the lymphoid system, the proliferation of donor ceils was substantial. By contrast, lymphoid organs of animals injected with CD81~ hi thymocytes failed to show any increase in CD4 + cells by 3-4 wk post injection, although some increase could be detected on days 10 and 15 post transfer (Table 2 and not shown). The percentage and numbers of total CD4 + cells in animals injected with CD81~ hl cells suggest that, before becoming undetectable, these cells probably did not undergo significant proliferation. For example, on day 15 (experiment 1), the spleens of animals injected with CD81~ hi cells were estimated to contain 2.1 x 106 cells of donor origin (after correction for the background). Since we did not have a congenic marker to follow the injected cells directly, we had to rely on numbers of CD8 and CD4 T cells as an indicator of the appearance, survival, and proliferation of T cells in recipient spleen and lymph nodes.
To avoid possible misinterpretation due to leakiness of nu/nu mice in our colony, we selected our recipients among mice containing less than 2% of T (CD4 + and CD8 +) cells in the peripheral blood. The results of our experiments clearly segregated into two groups. Uninjected and CD81~ -ted animals had identical baseline levels of T cells 4 wk and later, after the transfer. This was in contrast to animals injected with thymic and splenic CD8-4 hi cells, which displayed a selective increase in CD4 + and not CD8 + T cells. Furthermore, a small and selective increase in CD4 + cells was detected in animals receiving CD81~ hi cells (but not control animals) at early time points. Our assay therefore measured the proliferative ability (and, most likely, survival; see the next section) of transferred CD4 hi subsets, rather than their putative indirect effect on host T cells. Based on these results and on the results of apoptosis experiments (see below), we favor the explanation that CD81~ hs cells are probably not capable of surviving in peripheral lymphoid organs. However, since our approach could not formally prove that no CD81~ hi cells can be detected in recipient lymphoid organs, we have to allow an alternative explanation, namely that some CD81~ hi cells may have survived after transfer. Nevertheless, these cells are clearly incapable of expanding (Table 2) or functioning (Table 1) in peripheral lymphoid organs. Thus, we conclude that CD81~ hi thymocytes were capable of homing to, but were unable to proliferate (and may have failed to survive) in peripheral lymphoid organs.
CD81~ hi Thymocytes Are Susceptible to TCR-induced Apoptosis Despite
Their "Postselection" Phenotype. The inability of CD81~ h~ thymocytes to expand, (and, possibly, survive) upon syngeneic adoptive intravenous transfer prompted us to examine whether these cells would undergo apoptosis after TCR stimulation. TCR-induced DNA fragmentation was used as a quantitative readout of apoptosis. (The nature of apoptosis was confirmed by DNA "ladder" analysis, but this method was not quantitative for our purposes; data not shown.) The results of this analysis (Fig. 3) show a susceptibility of CD81~ hi thymocytes to TCR-induced apoptosis. By contrast, both CD8-4 h~ thymocytes and splenocytes were resistant. The apoptotic behavior of CD8b4 hi cells was thus reminiscent ofDP thymocytes in normal (29) and TCK transgenic (30, 31) mice. This was a surprising finding, given that CDSI~ hi thymocytes have almost completely downregulated their CD8 expression (which is detectable only by panning and not by direct FCM) and that they express the V~ repertoire associated with completed negative selection (32, 33) . Nevertheless, this finding may explain the failure of CD81~ hi cells to mediate GVHD, expand and perhaps even survive outside the thymus. Intrathymic Differentiation of CD8~4 hi Cells. We originally hypothesized that CD81~ hi thymocytes are precursors of CD8-4 hi cells, but other explanations were also plausible. For example, high susceptibility of CDSl~ hi thymocytes to apoptosis, and their inability to survive in peripheral lymphoid organs, suggested a possibility that CD81~ hi thymocytes are not precursors of thymic and peripheral CD8-4 hi cells, but are instead a dead-end population, marked for intrathymic death. However, this explanation is difficult to reconcile with the postselection phenotype of these cells. An alternative to this explanation, and the one in line with our initial hypothesis (13) was that CD81~ hi cells will become CD8-4 hi, but can only complete their differentiation in the presence of the thymic microenvironment. We sought to distinguish between these possibilities by performing intrathymic injections of Thy-l.2 + thymocyte and splenocyte subsets and analyzing the phenotype and function of their progeny in peripheral lymphoid organs of congenic (Thy-l.1 +) recipients. Intrathymic transfer of thymic and splenic CD8-4 hi cells gave rise to long-lived (>35 d) CD8-4 hi cells in the spleen (not shown) and mesenteric lymph nodes (Table 3) , with CD4/CD8 ratios among donor-derived cells of 20-60:1. It is likely that these cells simply migrated out of the thymus, populated the periphery, and proliferated there (1.75 x 106 injected cells yielded 1.5-2 x 106 cells in mesenteric lymph nodes and 5-8 x 106 cells in the spleen after 42 d; Table  3 and not shown). Similar numbers of donor-derived cells were obtained by transferring CD81~ hi cells, except that we consistently noted the presence of a small number of CD4-8 § cells. In this case, CD4/CD8 ratios varied between 8:1 and 14:1 (Tables 3 and 4 , and not shown). By contrast, intrathymic transfer of purified CD4-8-precursor thymocytes yielded peripheral progeny consisting of a physiological mixture of CD4-8 hi and CD8-4 hi SP cells in a CD4/CD8 ratio of 2:1, typically found in the donor strain of mice. Thus, although some cells in our CD81~ hi preparation developed into peripheral CD4-8 hi cells (most likely due to DN contamination, as discussed below), most of these cells gave rise to long-lived CDS-4 hi ceLls that populated peripheral lymphoid organs. A possible caveat of the above experiments lies in their long time course. This could magnify the contribution of occasional cross-contaminants to the outcome of these experiments. For example, if CD81~ hi cells were contaminated with CD8-4 hi cells at the moment of injection, it was possible that we actually detected the progeny of proliferating CD8-4 hi cells in the periphery. Since the results shown in Table 2 failed to show any evidence of peripheral expansion of such putative contaminants, the possibility remained that these contaminants proliferated intrathymically. Several lines of evidence speak against this possibility. (a) Panning, which was used to separate these two subsets, is an exquisitely sensitive and successful positive selection technique, but a relatively poor negative selection technique (7, 24, 34) . Therefore, a contamination would mostly occur in the reverse direction, such that the CD8-4 hi cells might contain some CD81~ hi cells, and not vice versa. Indeed, our results in Tables 1 and 2 strongly support this notion, since even the long-term (over 100 d) functional assays failed to reveal contamination of CD81~ ~ cells by CDS-4 ~ cells. (b) A number of reports from different laboratories, using thymocyte labeling with three different markers ([3H]TdR, bromodeoxyuridine (BrdU), and 7-amino-actinomycin D) had concluded that adult CD4 + SP thymocytes contain a negligible population of cycling cells (35) (36) (37) (38) . It is therefore extremely unlikely that CD4 + SP cells could proliferate to a significant degree intrathymicaUy. (c) Our results (Dyall, K., andJ. Nikoli6-Zugi~, unpublished results) show that CD4 SP thymocytes become undetectable in the thymus 10 d after the intrathymic injection. The long duration of our assay, which was necessary in order to ascertain that we are looking at bona fide longlived progeny of injected CD81~ hi cells, and not transient emigrants that will disappear (like those in experiment 1, Table 2 ), was therefore probably not a factor in light of low numbers of cycling SP cells and their relatively short intrathymic life. (d) Finally, our interpretation could indeed be questioned if all cycling CD4 § SP cells were to segregate with CD8-4 hi and none with CD81~ hi subset. To address this possibility, we purified thymocyte subsets and determined their cell cycle status using propidium iodide. This analysis Intrathymic injection (106 cells/recipient) and antibody treatment were performed as described in Fig. 3 . 5 wk later, pooled splenocytes (n = 3) were phenotyped for the coexpression of Thy-l.2 and either CD4 or CD8 (Unstimulated cells) and tested for their ability to proliferate in response to mitogenic stimulation (Stimulation) as described in Materials and Methods. Proliferating cells were also stained for the presence of donor-derived CD8 and CD4 cells (After culture). Results of phenotypic analysis are displayed as donor-type CD4/8 ratios and indices obtained by dividing the two. These parameters could not be determined for control B6.PL mice, (NA, not applicable) since their spleen cells underwent a pronounced depletion of T cells by the in vivo mAb treatment. * Results of the proliferation assay are displayed as stimulation indices, where SI = mean experimental cpm/mean control cpm. Actual cpm ( x 10 -3) were: 430.0 and 1.3 for BALB/c; 31.8 and 0.7 for DN; and 14.4 and 0.3 for the CD81o4 hi group, for experimental and control triplicates, respectively. Cultures without Con A were used as a control. (Fig. 4) ated vigorously in response to Con A, and the ratio of Thy-1.2 + CD4/CD8 among proliferating cells remained 3:1 (Table 4 ). B6.PL animals, treated with ctThy-l.1 mAb in vivo, contain <3% T (Thy-l.l+) cells and, under the experimental conditions in Table 4 , these cells failed to proliferate in response to Con A (very low proliferation was only noted with 5 x 10 s spleen cells/well; stimulation index = 2.9). Even though by FCM analysis these cells survived the in vivo depletion, most of them were probably damaged or functionally altered by such a treatment. Therefore, the extent of functional in vivo depletion was nearly complete, and allowed us to measure the proliferation of donor-derived cells in other experimental groups. Indeed, B6.PL animals injected intrathymically with either B6 DN or B6 CD81~ hi thymocytes contained •5% Thy-l.2 + thymocytes, and these cells vigorously responded to Con A ( 
Discussion
In this study, we have further characterized two subsets of CD4hiTCR ~ SP thymocytes. We extended their phenotypic characterization to show that our CD81~ hi cells, which appear CDS-by direct FCM, dearly differ from previously described CD81~ ~ cells (25) (26) (27) that bear intermediate levels of CD8 (4-5x lower than those on DP thymocytes), and that we therefore call CD8 int. In addition to the expression of CD8, the most pronounced differences between these two subsets were observed in the expression of TCR, CD24, and CD44. CD81~ hi cells were TCRhiCD24i~tCD44 hi, in contrast to CD8int4 hi cells which were TCRintCD24hiCD441~ Furthermore, the elimination of T cells bearing self-reactive Vos was complete in CD81~ hi cells, but not in CDS~t4 hi cells. This is consistent with the idea that our CD81~ hi cells are phenotypically more mature than CD8mt4 hi cells, although neither subset could produce IL-2 (13, 26) or IL-4 (Chiocchia, G. and R. Dyall, unpublished results). On the other hand, we witnessed high IL-2 and IL-4 production by CD8-4 ~i thymocytes in response to TCR ligation in vitro (Chiocchia, G., and R. Dyall, unpublished results), and, in that respect, our CD8-4 hi cells correspond to the analogous subset described by Bendelac et al. (26, 27) although the latter cells would also contain our CD81~ hi cells which are inactive in cytokine assays.
The main objective of this study was to test functional and developmental potential of CD81~ hi and CD8-4 hi cells in vivo. We documented the elimination of thymocytes bearing endogenous MMTV-reactive V~ TCKs in both subsets. This elimination is a late event in the thymocyte development (31, 32) and we can therefore conclude that, at least by phenotypic criteria, both subsets have undergone positive (TCK upregulation, reference 30) and negative selection. However, an in vivo examination of the functional behavior of these two subsets revealed profound differences. Whereas CD8-4 hi thymocytes and control mature peripheral CD8-4 hi cells induced lethal GVHD in allogeneic recipients and populated lymphoid organs of syngeneic recipients, CD81~ hi cells could not mount an immune response in vivo, and could not expand (and probably not survive longer than 3-4 wk) in peripheral lymphoid organs. Furthermore, CDSl~ hi cells were sensitive to TCK-induced apoptosis. It will therefore be of interest to examine the expression of the apoptosisprotective protooncogene bcl-2 and related genes in these subsets, since the expression of this molecule correlates very well to the stage of T cell development (39) (40) (41) and to the susceptibility of thymocyte subsets to Ca2+-induced apoptosis (41) .
After intrathymic injection, nonfunctional CD81~ hi thymocytes could mature into long-lived CD4 hi cells that populated peripheral lymphoid organs. Low numbers of donor derived cells precluded us from distinguishing whether the peripheral progeny of CD81~ hi ceils was CD8-or CD81~ but their longevity (Table 3) and immunocompetence (Table  4) suggested that these cells were CD8-. In most experiments, we could also observe a small population of CD4-8 hi ceUs that developed from the donor inoculum. These cells could develop from a few DN contaminants (between 0.2 and 2%, or 0.4-4 x 104 cells in our experiments) or could originate from a novel CD4hi8-/I~ thymic intermediate. This latter possibility would be supported by a finding of a similar thymocyte intermediate, but of TCK TM phenotype, in TCR transgenic and MHC-deficient mice (42) (43) (44) (45) (46) . Experiments are in progress to distinguish between these possibilities. Neverthdess, the presence of small numbers of contaminants could not influence the difference in CD4/CD8 ratios between the progeny of control DN and experimental CD81~ hi thymocytes. This difference was drastic (1.9 vs. 8.5), and it revealed that the latter cells were heavily biased towards becoming CD4 hi SP.
Most importantly, we could directly demonstrate that intrathymically injected CD81~ hi thymocytes yield functional CD4 hi SP progeny. Thus, our results demonstrate that most of the post-selectional CD4 hi SP thymocytes still need intrathymic signal(s) for final maturation. A recent report (31) has indicated that TCR hi DP cells from kl-2 transgenic and normal mice require the thymus to be processed into the CD8-4 hi lineage. We show here that a requirement for the thymic microenvironment exists very late in the T cell ontogeny, at the CD81~ hi stage, that is by a number of phenotypic and functional features very different from DP thymocytes. CD81~ hi thymocyte subset had undergone positive selection (as measured by the upregulation of TCK expression) on class II molecules (13, and this study); negative selection (as measured by the deletion of thymocytes bearing endogenous MMTV-reactive V~s) and an almost complete downregulation of CD8 + , but still requires the presence of the thymic microenvironment for final phenotypic and functional maturation. When CD81~ hi calls were taken out of the thymus, and allowed to populate peripheral lymphoid organs of a syngeneic recipient, they failed to complete development and become functional CD8-4 hi cells. These findings suggest the existence of a novel developmental control point that controls the final maturation of thymocytes.
The nature of the late signal(s) required by CD81~ hi cells is not known at present. Such a signal could be transmitted by class II molecules, in order to verify the correct pairing of class II-restricted TCK and CD4 at the surface of late thymocytes. If this is true, it would prove the stochastic model of accessory molecule exclusion (reviewed in 47, 48) correct. However, class II signal is probably insufficient by itsdf, since class II molecules cannot induce TCR hi DP thymocytes from bcl-2 transgenic mice to mature into CD8-4 hi cells (31) . An alternative hypothesis, and the one we favor, would be that CD81~ hi cells have indeed received all signals for downregulation of CD8, and that no further checks are required to test the TCR/accessory molecule matching. Instead, thymocytes at CD81~ hi (or CD41~ hi) stage would require intrathymic signal(s) to become functionally competent. This signal(s) would restore the capacity of late thymocytes to secrete cytokines (3) and could be mediated by a cytokine, a membrane contact, or both. The above hypotheses are testable in experiments with normal and class II-deficient animals and experiments are underway to distinguish between them.
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